Entremed, Inc (ENMD)

Company Overview
EntreMed, Inc., a clinical-stage biopharmaceutical company, engages in the development of oncology and antiinflammatory drugs. The company’s clinical drug candidates include Panzem (2-methoxyestradiol), which is in Phase 2 clinical trials for cancer, as well as in preclinical development for rheumatoid arthritis; MKC-1, a cell cycle inhibitor, which is in Phase 2 clinical trials for cancer; and ENMD-1198, a tubulin binding agent that is in Phase 1 clinical trials. Its preclinical product pipeline include 2ME2 for rheumatoid arthritis; MKC-1693, an aurora kinase inhibitor; Tubulin inhibitors that comprise a family of compounds that bind to tubulin and disrupt microtubules...
read more

Watch the video to learn about the probability of Entremed, Inc (ENMD) Chart Signal as of Apr 19 2014

Hotstocked Precision will calculate the probabilities of Entremed, Inc (ENMD)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads:
FREE DOWNLOAD

QUOTE

As of 06:39PM EDT April 19, 2014
$ 1.87   0 (0%)
Today's Open: 1.87 Previous Close: 1.87
Today's High: 1.87 Volume: 0
Today's Low: 1.87 Avg Vol: 29,039
52 Week High: 2.38 Bid (size): 1,100
52 Week Low: 1.45 Ask (size): 900

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: -
Mailing Address: 9640 MEDICAL CNTR SR STE 200 ROCKVILLE MD 20850 Business Address 9640 MEDICAL CNTR DR STE 200 ROCKVILLE MD 20850 3012179858 ENT
Phone: 240-864-2600
Fax: 240-864-2601
Website: http://www.entremed.com

Company Details:

Symbol: ENMD
SIC: -
State location: MD
Sector: -
State of Inc: DE
Employees: 13
Type: NASDAQ

Key executives:

Name Age Position
Carolyn Sidor 66 Chief Medical Officer, Corp. VP, Head of Research And Devel. and Member of Scientific Advisory Board
Cynthia Wong Esq. - VP, Sec. and Gen. Counsel
Dane Saglio 56 Chief Financial Officer and Principal Accounting Officer
James S. Burns 67 Chief Exec. Officer, Pres
Marc G. Corrado J.D., M.B.A. 49 VP of Corp. Devel.

Watch the video to learn about the probability of Entremed, Inc (ENMD) Chart Signal as of Apr 19 2014

This free program will calculate the probabilities of Entremed, Inc (ENMD) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads:
FREE DOWNLOAD

LATEST STOCK PROMOTIONS

PennyOmega.com Stocks In Action on Monday! Oct 03, 2011, 12:13

      EK, Eastman Kodak Co.   ** EK, in response to rumors circulating in the capital markets, reported that it is committed to meeting all of its obligations and has no intention of filing for bankruptcy.   EK helps consumers, businesses, and creative professionals unleash the power of images, information, and printing to enrich their lives.   More about EK at www.kodak.com   ******************   ENMD, read more

Promoter: pennyomega.com Paying Party: UNKNOWN Max Profit: 5.26 % Gain at close: -14.21 %
Stock: ENMD Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN

PennyToBuck.com Stocks In Action on Monday! Oct 03, 2011, 12:03

      EK, Eastman Kodak Co.   ** EK, in response to rumors circulating in the capital markets, reported that it is committed to meeting all of its obligations and has no intention of filing for bankruptcy.   EK helps consumers, businesses, and creative professionals unleash the power of images, information, and printing to enrich their lives.   More about EK at www.kodak.com   ******************   ENMD, read more

Promoter: penny to buck Paying Party: UNKNOWN Max Profit: 5.26 % Gain at close: -14.21 %
Stock: ENMD Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN

CRWESelect.com Stocks In Action on Monday! Oct 03, 2011, 12:02

      EK, Eastman Kodak Co.   ** EK, in response to rumors circulating in the capital markets, reported that it is committed to meeting all of its obligations and has no intention of filing for bankruptcy.   EK helps consumers, businesses, and creative professionals unleash the power of images, information, and printing to enrich their lives.   More about EK at www.kodak.com   ******************   ENMD, read more

Promoter: Crweselect.com Paying Party: UNKNOWN Max Profit: 5.26 % Gain at close: -14.21 %
Stock: ENMD Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN

ENTREMED, INC (ENMD) MESSAGE BOARD

Post # Subject Re Name Date
1 Do you know much about investment? I just... 0
2 Here on this message board we are inviting... 0